Table 4.
Meta-analyses | Systematic reviews | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Reference | Shin 2013(15) | Li 2013(14) | Rong 2013(29) | Alexander 2016(26) | Bechthold 2017(27) | Xu 2018(39) | Khawaja 2017(28) | Park 2008(23) | Tran 2014(21) | Geiker 2018(22) | Kerley† 2018(24,25) |
Mann et al. Heart. 1997 | X | ||||||||||
Hu et al. JAMA. 1999 | X* ‡ | X* ‡ | X* | X* | X* | X* | X | X | X | ||
Nakamura et al. AJCN. 2004 | X* ‡ | X* | X* | X | |||||||
Tanasescu et al. AJCN. 2004 | X‡ | ||||||||||
Nakamura et al. BJN. 2006 | X | X | X | X | X | X | |||||
Burke et al. Prev Med. 2007. | X | X | |||||||||
Qureshi et al. Med Sci Monit. 2007 | X‡ | X‡ | X‡ | X | X | X | X | X | X | ||
Nettleton et al. J Am Diet Assoc. 2008 | X | X | X | X | X | ||||||
Djousse & Gaziano. AJCN. 2008 | X | X | X‡ | X | X | X | X | X | X | X | X |
Djousse & Gaziano. Circulation. 2008 | X | X | X | X | |||||||
Bernstein et al. Circulation. 2010 | X | ||||||||||
Scrafford et al. Publ Health Nutr. 2011 | X* ‡ | X* ‡ | X* | X* | X | X | |||||
Houston et al. Nutr Metab Cardiovasc Dis. 2011 | X‡ | X‡ | |||||||||
Dilis et al. Br J Nutr. 2012 | X | ||||||||||
Goldberg et al. Atherosclerosis. 2014 | X | X | X | ||||||||
Haring et al. PLoS One. 2014 | X | X | |||||||||
Larsson et al. AJCN. 2015 | X* | X* | X* | X | X | X | |||||
Virtanen et al. AJCN. 2016 | X | X | X | ||||||||
Guangzhou Biobank Cohort Study 2018 | X |
Analysis was performed separately on the male and female cohorts.
Kerley review included discussion of, and reference to, the Khawaja et al., 2017 meta-analysis.
Studies that included data for CVD risk in T2DM population.